+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

Annals of the New York Academy of Sciences 854: 277-290

Oxidative stress is apparent in pathology associated with aging and many age-related, chronic diseases, including atherosclerosis, diabetes mellitus, rheumatoid arthritis, and neurodegenerative diseases. Although it cannot be measured directly in biological systems, several biomarkers have been identified that provide a measure of oxidative damage to biomolecules. These include amino acid oxidation products (methionine sulfoxide, ortho-tyrosine (o-tyr) and dityrosine, chlorotyrosine and nitrotyrosine), as well as chemical modifications of protein following carbohydrate or lipid oxidation, such as N epsilon-(carboxymethyl)lysine and N epsilon-(carboxyethyl)lysine, and malondialdehyde and 4-hydroxynonenal adducts to amino acids. Other biomarkers include the amino acid cross-link pentosidine, the imidazolone adducts formed by reaction of 3-deoxyglucosone or methylglyoxal with arginine, and the imidazolium cross-links formed by the reaction of glyoxal and methylglyoxal with lysine residues in protein. These compounds have been measured in short-lived intracellular proteins, plasma proteins, long-lived extracellular proteins, and in urine, making them valuable tools for monitoring tissue-specific and systemic chemical and oxidative damage to proteins in biological systems. They are normally measured by sensitive high-performance liquid chromatography or gas chromatography-mass spectrometry methods, requiring both complex analytical instrumentation and derivatization procedures. However, sensitive immunohistochemical and ELISA assays are now available for many of these biomarkers. Immunochemical assays should facilitate studies on the role of oxidative stress in aging and chronic disease and simplify the evaluation of therapeutic approaches for limiting oxidative damage in tissues and treating pathologies associated with aging and disease. In this article we summarize recent data and conclusions based on immunohistochemical and ELISA assays, emphasizing the strengths and limitations of the techniques.

(PDF emailed within 1 workday: $29.90)

Accession: 046333669

Download citation: RISBibTeXText

PMID: 9928437

Related references

Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease. Dementia & Neuropsychologia 2(1): 2-8, 2017

Antioxidant Activity/Capacity Measurement. 3. Reactive Oxygen and Nitrogen Species (ROS/RNS) Scavenging Assays, Oxidative Stress Biomarkers, and Chromatographic/Chemometric Assays. Journal of Agricultural and Food Chemistry 64(5): 1046-1070, 2016

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer's Disease 31(2): 439-445, 2013

Biomarkers of oxidative stress study VI. Endogenous plasma antioxidants fail as useful biomarkers of endotoxin-induced oxidative stress. Free Radical Biology & Medicine 81: 100-106, 2015

Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging?. Free Radical Biology & Medicine 48(5): 642-655, 2010

Effects of vitamin E depletion/repletion on biomarkers of oxidative stress in healthy aging. Annals of the New York Academy of Sciences 1031: 361-364, 2005

Inflammation and oxidative stress as biomarkers of premature aging in persons with intellectual disability. Research in Developmental Disabilities 33(2): 369-375, 2012

Reflections on the Theories of Aging, of Oxidative Stress, and of Science in General. Is It Time to Abandon the Free Radical (Oxidative Stress) Theory of Aging?. Antioxidants & Redox Signaling 23(3): 187-207, 2016

Elevated oxidative DNA damage in patients with coronary artery disease and its association with oxidative stress biomarkers. Acta Cardiologica: 1-8, 2018

Immunohistochemical detection of oxidative stress biomarkers, dityrosine and N(epsilon)-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. Journal of Atherosclerosis and Thrombosis 15(4): 185-192, 2008

Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men. Nutrition, Metabolism, and Cardiovascular Diseases 21(10): 792-799, 2012

Positive oxidative stress in aging and aging-related disease tolerance. Redox Biology 2: 165-169, 2014

A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks. Journal of Alzheimer's Disease 62(3): 1319-1335, 2018

Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress?. Free Radical Biology & Medicine 50(12): 1787-1793, 2011

Oxidative stress, aging, and central nervous system disease in the canine model of human brain aging. Veterinary Clinics of North America. Small Animal Practice 38(1): 167-78, Vi, 2008